Predictmedix Inc. Secures Strategic Financing to Catalyze Operations

NEXT STORY
Ocuphire Announces Publication of MIRA-1 Phase 2b Results in Optometry and Visual Science Demonstrating Reduction of Pharmacologically Induced Mydriasis by Nyxol®
PREV STORY
Claritas (formerly Kalytera Therapeutics, Inc.) Announces Addition of Professor Salvatore Cuzzocrea, Ph.D. to the Company’s Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release April 7, 2017 at 10:00 EET Conversion of FIT ...

author_avatar
NASDAQ Market News

OpGen and Curetis Successfully Close their Business Combination Transaction

author_avatar
NASDAQ Market News

Chembio Diagnostics to Report First Quarter 2018 Financial Results on May 9, 2018

author_avatar
NASDAQ Market News